Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnold C Satterthwait

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The Journal of Biological Chemistry|October 1, 2003
Structurally distinct recognition motifs in lymphotoxin-beta receptor and CD40 for tumor necrosis factor receptor-associated factor (TRAF)-mediated signalingChenglong Li, Paula S Norris, Chao-Zhou Ni, et al.
Assay and Drug Development Technologies|May 13, 2011
High-throughput screen for the chemical inhibitors of antiapoptotic bcl-2 family proteins by multiplex flow cytometryRamona F Curpan, Peter C Simons, Dayong Zhai, et al.
Blood|January 18, 2007
Nur77 converts phenotype of Bcl-B, an antiapoptotic protein expressed in plasma cells and myelomaFrederic Luciano, Maryla Krajewska, Paulina Ortiz-Rubio, et al.
Oncotarget|June 15, 2018
Induction of apoptosis and suppression of tumor growth by Nur77-derived Bcl-2 converting peptide in chemoresistant lung cancer cellsMartin C Pearce, John T Gamble, Prasad R Kopparapu, et al.
Cancer Cell|October 7, 2008
A short Nur77-derived peptide converts Bcl-2 from a protector to a killerSiva Kumar Kolluri, Xiuwen Zhu, Xin Zhou, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The Journal of Biological Chemistry|October 1, 2003
Structurally distinct recognition motifs in lymphotoxin-beta receptor and CD40 for tumor necrosis factor receptor-associated factor (TRAF)-mediated signalingChenglong Li, Paula S Norris, Chao-Zhou Ni, et al.
Assay and Drug Development Technologies|May 13, 2011
High-throughput screen for the chemical inhibitors of antiapoptotic bcl-2 family proteins by multiplex flow cytometryRamona F Curpan, Peter C Simons, Dayong Zhai, et al.
Blood|January 18, 2007
Nur77 converts phenotype of Bcl-B, an antiapoptotic protein expressed in plasma cells and myelomaFrederic Luciano, Maryla Krajewska, Paulina Ortiz-Rubio, et al.
Oncotarget|June 15, 2018
Induction of apoptosis and suppression of tumor growth by Nur77-derived Bcl-2 converting peptide in chemoresistant lung cancer cellsMartin C Pearce, John T Gamble, Prasad R Kopparapu, et al.
Cancer Cell|October 7, 2008
A short Nur77-derived peptide converts Bcl-2 from a protector to a killerSiva Kumar Kolluri, Xiuwen Zhu, Xin Zhou, et al.
Pageof 2